Icon sets share income forecast

ICON Plc, Ireland’s largest provider of clinical research for drugmakers, forecast net income per share to range between $2.27 (€1.58) and $2.36 next year.

This year’s net income is forecast to be as much as $1.85 a share, the Dublin-based company said yesterday.

Net sales may be between $750 million (€521m) and $770m in 2008, compared with as much as $625m this year, it said.

Icon said in October that it won $230m of new business during the third quarter.